Christopher Durant Turner, Chief Medical Officer at Nuvalent, Inc. (NUVL), sold 10,060 shares at $46.85 ($482K) on 2023-07-26, disclosed to the SEC on 2023-07-28.
Scheduled sale ($482k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.85 | 2,365 | $111K | 23.0% |
| 2 | $46.85 | 2,365 | $111K | 23.0% |
| 3 | $48.93 | 2,665 | $130K | 27.0% |
| 4 | $48.93 | 2,665 | $130K | 27.0% |
| Total | $47.95 avg | 10,060 | $482K | 100% |
| Filing → |
| NUVL | SELL | 2023-10-06 | $775K | — | Filing → |
| NUVL | SELL | 2023-07-24 | $14K | — | Filing → |
| NUVL | SELL | 2023-06-07 | $918K | — | Filing → |